Browsing by Author "Kumarasamy, Nagalingeswaran"
Now showing items 21-40 of 40
-
Insulin-Like Growth Factor Is Associated with Changes in Body Composition with Antiretroviral Therapy Initiation
Erlandson, Kristine M et al. | Date Issued: 2017 -
Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease
Périssé, André R. S. et al. | Date Issued: 2013 -
Phylogenetic methods inconsistently predict direction of HIV transmission among heterosexual pairs in the HPTN052 cohort
Rose, Rebecca et al. | Date Issued: 2018 -
Phylogenetic methods inconsistently predict the direction of HIV transmission among heterosexual pairs in the HPTN 052 cohort
Rose, Rebecca et al. | Date Issued: 2019 -
Pre-cART elevation of CRP and CD4+ T-Cell immune activation associated with HIV clinical progression in a multinational case-cohort study
Balagopal, Ashwin et al. | Date Issued: 2015 -
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
Salata, Robert A. et al. | Date Issued: 2023 -
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Cohen, Myron S. et al. | Date Issued: 2011 -
Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial
Safren, Steven A. et al. | Date Issued: 2014 -
A randomized comparison of anthropomorphic changes with preferred and alternative efavirenz-based antiretroviral regimens in diverse multinational Settings
Erlandson, Kristine M. et al. | Date Issued: 2015 -
Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003)
Swindells, Susan et al. | Date Issued: 2018 -
Safety and Efficacy of Darunavir/Ritonavir in Treatment-experienced Pediatric Patients: Week 48 Results of the ARIEL Trial
Violari, Avy et al. | Date Issued: 2015Background: ARIEL (Darunavir in treatment-experienced pediatric population) was a phase II, open-label study assessing safety and antiviral activity of darunavir/ritonavir twice daily with an optimized background ... -
Sex-related differences in inflammatory and immune activation markers before and after combined antiretroviral therapy initiation
Mathad, Jyoti S. et al. | Date Issued: 2016 -
Sex-related Differences in Inflammatory and Immune Activation Markers before and after combined Antiretroviral Therapy Initiation
Mathad, Jyoti S. et al. | Date Issued: 2016 -
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study
Grinsztejn, Beatriz et al. | Date Issued: 2019 -
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial
Eshleman, Susan H. et al. | Date Issued: 2017 -
Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)
Fogel, Jessica M. et al. | Date Issued: 2013 -
Virologic outcomes in early antiretroviral treatment: HPTN 052
Eshleman, Susan H. et al. | Date Issued: 2017